Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Sell
38,375
-27,669
-42% -$12.8M 0.09% 190
2026
Q1
$31.7M Sell
66,044
-29,234
-31% -$15M 0.15% 126
2025
Q4
$53.5M Buy
95,278
+29,907
+46% +$17M 0.16% 74
2025
Q3
$33.6M Buy
65,371
+42,570
+187% +$18.6M 0.1% 104
2025
Q2
$7.16M Buy
22,801
+517
+2% +$155K 0.04% 328
2025
Q1
$6.79M Sell
22,284
-4,922
-18% -$1.66M 0.05% 268
2024
Q4
$9.04M Buy
27,206
+24,921
+1,091% +$8.45M 0.09% 150
2024
Q3
$763K Buy
+2,285
New +$868K 0.01% 620

Other funds holding MEDP

IEQ Capital's MEDP Position: Q2 2026 in Review

IEQ Capital reduced its Medpace (MEDP) stake by 42% in Q2 2026, selling an estimated $12.8M and leaving 38,375 shares worth $20.3M. The position accounts for 0.09% of the portfolio, ranked #190.

IEQ Capital first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. The position peaked at $53.5M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • IEQ Capital held 38,375 shares of Medpace worth $20.3M as of Q2 2026.
  • IEQ Capital sold 27,669 Medpace shares in Q2 2026, an estimated $12.8M.
  • Medpace made up 0.09% of IEQ Capital's portfolio in Q2 2026, its #190 holding.
  • IEQ Capital first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • IEQ Capital's Medpace position peaked at $53.5M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.